Search hospitals > Connecticut > West Haven
VA Connecticut Healthcare System
Claim this profileWest Haven, Connecticut 06516
Global Leader in Lung Cancer
Global Leader in Substance Abuse
Conducts research for Post-Traumatic Stress Disorder
Conducts research for Alcohol-Related Intimate Partner Violence
Conducts research for Schizophrenia
280 reported clinical trials
32 medical researchers
Summary
VA Connecticut Healthcare System is a medical facility located in West Haven, Connecticut. This center is recognized for care of Lung Cancer, Substance Abuse, Post-Traumatic Stress Disorder, Alcohol-Related Intimate Partner Violence, Schizophrenia and other specialties. VA Connecticut Healthcare System is involved with conducting 280 clinical trials across 408 conditions. There are 32 research doctors associated with this hospital, such as Herta H. Chao, Mohini Ranganathan, MD, Deepak C. D'Souza, M.D., and Joao P. De Aquino, M.D..Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Substance Abuse
Global LeaderTop PIs
Herta H. ChaoVeterans Affairs Connecticut Healthcare System-West Haven Campus4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
29 drugs studied
Mohini Ranganathan, MDConnecticut Mental Health Center4 years of reported clinical research
Studies Substance Abuse
Studies Healthy Subjects
8 reported clinical trials
11 drugs studied
Deepak C. D'Souza, M.D.Biological Studies Unit, VA Connecticut Healthcare System4 years of reported clinical research
Studies Substance Abuse
Studies Cannabis
8 reported clinical trials
11 drugs studied
Joao P. De Aquino, M.D.VA Healthcare System6 years of reported clinical research
Studies Chronic Persistent Surgical Pain
Studies Pain
4 reported clinical trials
4 drugs studied
Clinical Trials running at VA Connecticut Healthcare System
Lung Cancer
Prostate Cancer
Post-Traumatic Stress Disorder
Bladder Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Depression
Small Cell Lung Cancer
Cancer
Substance Abuse
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at VA Connecticut Healthcare System?
VA Connecticut Healthcare System is a medical facility located in West Haven, Connecticut. This center is recognized for care of Lung Cancer, Substance Abuse, Post-Traumatic Stress Disorder, Alcohol-Related Intimate Partner Violence, Schizophrenia and other specialties. VA Connecticut Healthcare System is involved with conducting 280 clinical trials across 408 conditions. There are 32 research doctors associated with this hospital, such as Herta H. Chao, Mohini Ranganathan, MD, Deepak C. D'Souza, M.D., and Joao P. De Aquino, M.D..
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.